Viewing Study NCT01521702


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-05-17 @ 4:37 PM
Study NCT ID: NCT01521702
Status: COMPLETED
Last Update Posted: 2015-03-20
First Post: 2011-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer
Sponsor:
Organization: